Arena Pharmaceuticals reported $40.03M in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
Alnylam Pharmaceuticals ALNY:US $ 191.59M 0.31M
Amgen AMGN:US $ 31129M 1766M
Arena Pharmaceuticals ARNA:US $ 40.03M 1.18M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cara Therapeutics CARA:US $ 0 0
Cytokinetics CYTK:US $ 131.76M 3.95M
Eisai 4523:JP Y 49908M 39976M
Esperion Therapeutics ESPR:US $ 271.69M 92.33M
GlaxoSmithKline GSK:LN 20442M 2605M
Halozyme Therapeutics HALO:US $ 784.73M 784.73M
Intra Cellular Therapies ITCI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Tg Therapeutics TGTX:US $ 0M 7.72M
Therapeuticsmd TXMD:US 178.97M 58.73M
United Therapeutics UTHR:US $ 800M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 569.75M 39.42M
Ziopharm Oncology ZIOP:US $ 0M 0M